StockData

Neutra Corp. (NTRR) stock

NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Neutra operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Neutra's operating income for the twelve months ending Oct 31, 2023 was -$253.49K. For fiscal 2023 it was -$297.68K. The highest annual figure on record is -$81.22K in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2023Jan 31, 2023-$297.68K–
FY2022Jan 31, 2022-$583.58K–
FY2021Jan 31, 2021-$478.67K–
FY2020Jan 31, 2020-$394.25K–
FY2019Jan 31, 2019-$1.71M–
FY2018Jan 31, 2018-$163.68K–
FY2017Jan 31, 2017-$370.73K–
FY2016Jan 31, 2016-$1.04M–
FY2015Jan 31, 2015-$635.87K–
FY2014Jan 31, 2014-$965.90K–
FY2013Jan 31, 2013-$308.06K–
FY2012Jan 31, 2012-$81.22K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2024CQ3 2023Oct 31, 2023-$52.73K–
Q2 FY2024CQ2 2023Jul 31, 2023-$71.77K–
Q1 FY2024CQ1 2023Apr 30, 2023-$71.21K–
Q4 FY2023CQ4 2022Jan 31, 2023-$57.79K–
Q3 FY2023CQ3 2022Oct 31, 2022-$66.07K–
Q2 FY2023CQ2 2022Jul 31, 2022-$82.35K–
Q1 FY2023CQ1 2022Apr 30, 2022-$91.46K–
Q4 FY2022CQ4 2021Jan 31, 2022-$160.67K–
Q3 FY2022CQ3 2021Oct 31, 2021-$175.11K–
Q2 FY2022CQ2 2021Jul 31, 2021-$125.10K–
Q1 FY2022CQ1 2021Apr 30, 2021-$122.70K–
Q4 FY2021CQ4 2020Jan 31, 2021-$249.07K–
Q3 FY2021CQ3 2020Oct 31, 2020-$94.22K–
Q2 FY2021CQ2 2020Jul 31, 2020-$86.86K–
Q1 FY2021CQ1 2020Apr 30, 2020-$48.52K–
Q4 FY2020CQ4 2019Jan 31, 2020-$88.81K–
Q3 FY2020CQ3 2019Oct 31, 2019-$180.79K–
Q2 FY2020CQ2 2019Jul 31, 2019-$57.70K–
Q1 FY2020CQ1 2019Apr 30, 2019-$66.95K–
Q4 FY2019CQ4 2018Jan 31, 2019-$75.89K–
Q3 FY2019CQ3 2018Oct 31, 2018-$1.51M–
Q2 FY2019CQ2 2018Jul 31, 2018-$62.35K–
Q1 FY2019CQ1 2018Apr 30, 2018-$63.85K–
Q4 FY2018CQ4 2017Jan 31, 2018-$47.40K–
Q3 FY2018CQ3 2017Oct 31, 2017-$25.84K–
Q2 FY2018CQ2 2017Jul 31, 2017-$34.54K–
Q1 FY2018CQ1 2017Apr 30, 2017-$55.90K–
Q4 FY2017CQ4 2016Jan 31, 2017-$95.11K–
Q3 FY2017CQ3 2016Oct 31, 2016-$67.16K–
Q2 FY2017CQ2 2016Jul 31, 2016-$94.11K–
Q1 FY2017CQ1 2016Apr 30, 2016-$114.35K–
Q4 FY2016CQ4 2015Jan 31, 2016-$646.17K–
Q3 FY2016CQ3 2015Oct 31, 2015-$143.97K–
Q2 FY2016CQ2 2015Jul 31, 2015-$109.88K–
Q1 FY2016CQ1 2015Apr 30, 2015-$136.01K–
Q4 FY2015CQ4 2014Jan 31, 2015-$121.85K–
Q3 FY2015CQ3 2014Oct 31, 2014-$164.00K–
Q2 FY2015CQ2 2014Jul 31, 2014-$211.63K–
Q1 FY2015CQ1 2014Apr 30, 2014-$138.39K–
Q4 FY2014CQ4 2013Jan 31, 2014-$260.37K–

More Neutra figures

See a number that looks wrong?